목적: The aim of present study was to investigate factors predicting response of treatments in Burning Mouth Syndrome (BMS) patients. 방법:The medical records of 19 (2 males and 17 females) patients, who treated at the Department of the OtorhinolaryngologyHead and Neck Surgery in Korea University Ansan Hospital between May 2014 and January 2015 with the diagnosis of BMS, were retrospectively reviewed.The response group (8 patients, 42.11%) was defined as a group of subjects whose follow-up Oral Health Impact Profile-14 (OHIP-14) value is higher than initial one. Any other subjects were included in the non-response group (11 patients, 57.89%). Demographic data, lab profile for BMS, and components of OHIP-14 were compared between two groups. 결과:Although the response group had young age (mean age, 57.50 vs. 59.64 years), high vitamin B12 (mean value, 802.50 vs. 644.55 pg/mL), high folate (mean value, 18.11 vs. 11.66 ng/mL) and high lactate (mean value, 1.44 vs. 1.10 mmol/L) than the non-response group, the results were not statistically significant (p > 0.05).In contrast, in the response group, initial OHIP-14 score were lower than than the non-response group (mean value, 35.50 vs. 48.09, p < 0.05). It means that patients with more severe symptoms may responds to the treatments more often. 결론:Initial OHIP-14 score may have a prognostic value in patients with burning mouth syndrome.